Early treatment of idiopathic Parkinson's disease with dopaminergic agonist piribedil in monotherapy. A two-year randomised, parallel, placebo-controlled study in idiopathic Parkinsonian de novo patients
2009 ◽
Vol 37
(3)
◽
pp. 537-544
◽
2016 ◽
Vol 123
(6)
◽
pp. 601-610
◽
2015 ◽
Vol 123
(3)
◽
pp. 211-217
◽
1999 ◽
Vol 98
(2)
◽
pp. 214-220
◽
2018 ◽
Vol 392
◽
pp. 3-7
◽
2008 ◽
Vol 35
(12)
◽
pp. 2220-2226
◽
1989 ◽
Vol 48
(3-4)
◽
pp. 205-217
◽